Résultat(s) 1 - 4 résultats de 4 pour la requête '"architect"', Temps de recherche: 0,06s Affiner les résultats
  1. 1
    “…Newer 4(th)-generation, antigen-antibody combo rapid immunoassay (ARCHITECT) detected HIV in 87 percent of all the acute cases that had been missed by one of the previous screening assays. …”
    Accéder au texte intégral
    Accéder au texte intégral
    Accéder au texte intégral
    Online Article Texte
    Performance of Rapid Point-of-Care and Laboratory Tests for Acute and Established HIV Infection in San Francisco
  2. 2
    “…Prevalence by PCR and seroprevalence combining data from two forms of antibody testing were performed in parallel (Abbott ARCHITECT IgG to nucleocapsid protein and in-house IgG ELISA to the receptor binding domain). …”
    Accéder au texte intégral
    Accéder au texte intégral
    Accéder au texte intégral
    Online Article Texte
    Universal PCR and antibody testing demonstrate little to no transmission of SARS-CoV-2 in a rural community
  3. 3
    par Peluso, Michael J., Takahashi, Saki, Hakim, Jill, Kelly, J. Daniel, Torres, Leonel, Iyer, Nikita S., Turcios, Keirstinne, Janson, Owen, Munter, Sadie E., Thanh, Cassandra, Nixon, Christopher C., Hoh, Rebecca, Tai, Viva, Fehrman, Emily A., Hernandez, Yanel, Spinelli, Matthew A., Gandhi, Monica, Palafox, Mary-Ann, Vallari, Ana, Rodgers, Mary A., Prostko, John, Hackett, John, Trinh, Lan, Wrin, Terri, Petroplolous, Christos J., Chiu, Charles Y., Norris, Philip J., DiGermanio, Clara, Stone, Mars, Busch, Michael P., Elledge, Susanna K., Zhou, Xin X., Wells, James A., Shu, Albert, Kurtz, Theodore W., Pak, John E., Wu, Wesley, Burbelo, Peter D., Cohen, Jeffrey I., Rutishauser, Rachel L., Martin, Jeffrey N., Deeks, Steven G., Henrich, Timothy J., Rodriguez-Barraquer, Isabel, Greenhouse, Bryan
    Publié 2021
    “…Variations in sensitivity and durability were particularly dramatic for individuals with mild infection, who had consistently lower antibody titers and represent the majority of the infected population, with sensitivities often differing substantially from reported test characteristics (e.g., amongst commercial assays, sensitivity at 6 months ranged from 33% for ARCHITECT IgG to 98% for VITROS Total Ig). Thus, the ability to detect previous infection by SARS-CoV-2 is highly dependent on the severity of the initial infection, timing relative to infection, and the assay used. …”
    Accéder au texte intégral
    Accéder au texte intégral
    Accéder au texte intégral
    Online Article Texte
    SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
  4. 4
    “…Prevalence by PCR and seroprevalence from 2 forms of antibody testing were performed in parallel (Abbott ARCHITECT immunoglobulin [Ig]G and in-house IgG enzyme-linked immunosorbent assay). …”
    Accéder au texte intégral
    Accéder au texte intégral
    Accéder au texte intégral
    Online Article Texte
    Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community
Outils de recherche: S'abonner aux flux RSS